ROSE PHARMA A/S: Financial statements 2014
CVR: 27174965
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ROSE PHARMA A/S (CVR 27174965) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 262,551 and a net result of DKK 249,739 compared with DKK -133,626 the year before. Equity in the 2014 report amounted to DKK 1,218,053. The solvency ratio was 84.6%.
- Gross Profit
- DKK 262,551
- Profit/Loss
- DKK 249,739
- Equity
- DKK 1,218,053
- Total Assets
- DKK 1,439,308
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 263 t. | 250 t. | 1.2 mio. | - |
| 2013 | - | -130 t. | -134 t. | 968 t. | - |
| 2012 | - | -335 t. | -335 t. | 1.1 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
ROSE PHARMA A/S has published its annual report for 2013. Gross profit came to DKK -129,734, and the net result was DKK -133,626.
About ROSE PHARMA A/S
ROSE PHARMA A/S was a Danish company of the type Aktieselskab based in Roskilde, founded in 2003. The company has been dissolved on 23 April 2020. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named GASTROTECH PHARMA A/S and GASTROTECH A/S. The company has 1 employee (2007). In 2016, the company reported a gross profit of DKK -35,218 and a net result of DKK -51,821 compared with DKK -186,905 the year before. Equity in the 2016 report amounted to DKK 979,327.